Значения термина testis cancer на английском

Objective: To review the available literature concerning the management of postchemotherapy testis cancer.

Advanced stage nonseminomatous testis cancer is commonly treated with chemotherapy and surgical resection.

Context: Some controversy still exists regarding the management of testis cancer following chemotherapy for disseminated disease.

The National Health Service in the U.K. stipulates various testis cancer care modalities be delivered through supra-regional network.

Recurrence of teratoma or carcinoma in testis cancer patients found to have teratoma at post-chemotherapy retroperitoneal lymphadenectomy is well recognized.

Desmoid tumor should be included in the differential diagnosis of tumor recurrence in testis cancer patients previously subjected to post-chemotherapy retroperitoneal lymphadenectomy.

It was acknowledged that non-guideline-concordant care in testis cancer occurs frequently, in the range of 18-30%.

Until clinical staging improves, patients presenting with clinical stage A nonseminomatous testis cancer should be offered the option of initial nerve-sparing RPLND versus surveillance.

The principles of dose-response and combination chemotherapy were basic to the design of the initial curative standard-dose treatment regimens for leukemias, lymphomas, and testis cancer.

At the Canadian Testis Cancer Workshop, the rationale and feasibility of regionalization of testis cancer care were discussed.

An International Testis Cancer Linkage Consortium has been formed to pool resources and will investigate these findings further with the world-wide collection of families.